Search all trials

Find therapies in clinical trials near you – page 57

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Nivolumab with Ipilimumab or Nivolumab with Chemotherapy to Chemotherapy Alone in Patients with Early Stage Non-Small Cell Lung Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Tourette's disorder

Not recruiting

Investigational

Study on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette's Disorder

Investigational

Italy

Participants:0–17 years · 18–64 years
Substances:Ecopipam Hydrochloride

Contact Research Centre

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Not recruiting

Registered drugNo placebo

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Neurotrophic keratopathy

Not recruiting

Investigational

Study on the Safety and Effectiveness of RGN-259 Eye Drops for Patients with Neurotrophic Keratopathy

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Timbetasin Acetate

Contact Research Centre

Focal segmental glomerulosclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of DMX-200 with Losartan in Adults with Focal Segmental Glomerulosclerosis

Registered drug

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Azilsartan Medoxomil

Contact Research Centre

Cardiovascular disorder

Not recruiting

Registered drug

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Small cell lung cancer recurrent

Not recruiting

Registered drugNo placebo

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ammonium Chloride

Contact Research Centre

Epilepsy

Not recruiting

InvestigationalNo placebo

Study on Ganaxolone for Children and Adults with Epilepsy Related to Tuberous Sclerosis Complex

InvestigationalNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Ganaxolone

Contact Research Centre

Thalassaemia alpha

Not recruiting

Registered drug

Study on Luspatercept for Treating Anemia in Adults and Adolescents with Alpha-Thalassemia

Registered drug

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Luspatercept

Contact Research Centre

Cardiac failure+1

Not recruiting

Investigational

Study of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Azd3427

Contact Research Centre

Open angle glaucoma+2

Not recruiting

Investigational

Study on the Effectiveness of Citicoline Eye Drops for Visual Field Preservation in Patients with Open Angle Glaucoma

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Citicoline Sodium

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drug

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Loperamide

Contact Research Centre

Find therapies in clinical trials near you – page 57

706 trials match your criteria

Non-small cell lung cancer

Study Comparing Nivolumab with Ipilimumab or Nivolumab with Chemotherapy to Chemotherapy Alone in Patients with Early Stage Non-Small Cell Lung Cancer

Tourette's disorder

Study on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette's Disorder

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Neurotrophic keratopathy

Study on the Safety and Effectiveness of RGN-259 Eye Drops for Patients with Neurotrophic Keratopathy

Focal segmental glomerulosclerosis

Study on the Effectiveness and Safety of DMX-200 with Losartan in Adults with Focal Segmental Glomerulosclerosis

Cardiovascular disorder

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Small cell lung cancer recurrent

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Epilepsy

Study on Ganaxolone for Children and Adults with Epilepsy Related to Tuberous Sclerosis Complex

Thalassaemia alpha

Study on Luspatercept for Treating Anemia in Adults and Adolescents with Alpha-Thalassemia

Cardiac failure+1

Study of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease

Open angle glaucoma+2

Study on the Effectiveness of Citicoline Eye Drops for Visual Field Preservation in Patients with Open Angle Glaucoma

Endometrial cancer

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.